These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29668740)

  • 1. Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.
    Bártolo I; Diniz AR; Borrego P; Ferreira JP; Bronze MR; Barroso H; Pinto R; Cardoso C; Pinto JF; Diaz RC; Broncano PG; Muñoz-Fernández MA; Taveira N
    PLoS One; 2018; 13(4):e0195744. PubMed ID: 29668740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety Assessment of Microbicide 2P23 on the Rectal and Vaginal Microbiota and Its Antiviral Activity on HIV Infection.
    Gao Z; Fu R; Li X; Wang J; He Y
    Front Immunol; 2021; 12():702172. PubMed ID: 34447373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS.
    Gupta SK; Nutan
    HIV AIDS (Auckl); 2013 Oct; 5():295-307. PubMed ID: 24174883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides.
    Tong P; Lu Z; Chen X; Wang Q; Yu F; Zou P; Yu X; Li Y; Lu L; Chen YH; Jiang S
    J Antimicrob Chemother; 2013 Nov; 68(11):2533-44. PubMed ID: 23794600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.
    Notario-Pérez F; Ruiz-Caro R; Veiga-Ochoa MD
    Drug Des Devel Ther; 2017; 11():1767-1787. PubMed ID: 28670111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR; Kiser PF
    Antiviral Res; 2013 Sep; 99(3):391-400. PubMed ID: 23845918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbicides for HIV prevention: reality or hope?
    McGowan I
    Curr Opin Infect Dis; 2010 Feb; 23(1):26-31. PubMed ID: 19935418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides.
    Briz V; Sepúlveda-Crespo D; Diniz AR; Borrego P; Rodes B; de la Mata FJ; Gómez R; Taveira N; Muñoz-Fernández MÁ
    Nanoscale; 2015 Sep; 7(35):14669-83. PubMed ID: 26274532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation.
    Roberts L; Liebenberg L; Barnabas S; Passmore JA
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):441-9. PubMed ID: 22429786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.
    Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H
    J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.
    Kish-Catalone TM; Lu W; Gallo RC; DeVico AL
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1497-509. PubMed ID: 16569870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.
    Ham AS; Ugaonkar SR; Shi L; Buckheit KW; Lakougna H; Nagaraja U; Gwozdz G; Goldman L; Kiser PF; Buckheit RW
    J Pharm Sci; 2012 Apr; 101(4):1423-35. PubMed ID: 22227864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbicides for multidrug-resistant and multitropic HIV-1.
    D'Cruz OJ; Uckun FM
    Curr Opin Investig Drugs; 2008 Feb; 9(2):152-69. PubMed ID: 18246518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
    El-Sadr WM; Mayer KH; Maslankowski L; Hoesley C; Justman J; Gai F; Mauck C; Absalon J; Morrow K; Mâsse B; Soto-Torres L; Kwiecien A
    AIDS; 2006 May; 20(8):1109-16. PubMed ID: 16691061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.
    Yang J; Li L; Jin H; Tan S; Qiu J; Yang L; Ding Y; Jiang ZH; Jiang S; Liu S
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1498-508. PubMed ID: 22867271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity.
    Borrego P; Calado R; Marcelino JM; Pereira P; Quintas A; Barroso H; Taveira N
    AIDS; 2013 Apr; 27(7):1081-90. PubMed ID: 23324659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbicides for prevention of HIV infection: clinical efficacy trials.
    Abdool Karim SS; Baxter C
    Curr Top Microbiol Immunol; 2014; 383():97-115. PubMed ID: 23695725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal deployment and tenofovir delivery by microbicide gels.
    Gao Y; Yuan A; Chuchuen O; Ham A; Yang KH; Katz DF
    Drug Deliv Transl Res; 2015 Jun; 5(3):279-94. PubMed ID: 25874971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal microbicides and the prevention of HIV transmission.
    Cutler B; Justman J
    Lancet Infect Dis; 2008 Nov; 8(11):685-97. PubMed ID: 18992405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.